Akari Therapeutics Plc Additional Collateral, Aggregate Fair Value
Financial Statements › Notes
us-gaap:AdditionalCollateralAggregateFairValue · last filed 2026-08-13
- 2025-12-17: Additional Collateral, Aggregate Fair Value $2.00M.
- 2024-11-30: Additional Collateral, Aggregate Fair Value $191.80K.
| Period end | Additional Collateral, Aggregate Fair Value |
|---|---|
| 2025-12-17 | $2.00M 10-K · filed 2026-03-30 |
| 2024-11-30 | $191.80K 10-Q · filed 2026-08-13 |